- Repligen Announces Pricing of $100 Million of 2.125% Convertible ...🔍
- Repligen RGEN shares close up 20% on acquisition of ...🔍
- Repligen Reports Fourth Quarter and Full Year 2023 Financial Results🔍
- Repligen Reports Third Quarter 2023 Financial Results ...🔍
- REPLIGEN CORP 🔍
- Repligen Corporation🔍
- Should You Investigate Repligen Corporation 🔍
- Is It Time To Consider Buying Repligen Corporation 🔍
Repligen Corporation Common Stock
Repligen Announces Pricing of $100 Million of 2.125% Convertible ...
The conversion rate for the Notes will initially be 31.1813 shares of the Company's common stock per $1,000 principal amount of Notes, which is ...
Repligen RGEN shares close up 20% on acquisition of ...
Repligen Corporation (NASDAQ: RGEN) shares ... for approximately $240m, comprised of $192m in cash plus $48m in Repligen common stock.
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) ... shares of the Company's common stock. Therefore, from March 5, 2022 ...
Repligen (RGEN) Announces Private Convertible Transaction of ...
The conversion price for the New Notes will initially be approximately $203.06 per share of Repligen's common stock, which represents a ...
Repligen Reports Third Quarter 2023 Financial Results ... - BioSpace
Repligen Corporation (NASDAQ:RGEN), a life sciences company ... shares of the Company's common stock. Therefore, from March 5, 2022 ...
REPLIGEN CORP (Form: S-8, Received - EDGAR Online
This Registration Statement relates to 2,000,000 shares of Common Stock, par value $0.01 per share, of Repligen Corporation (“Common Stock”) available for ...
(RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS ...
Repligen Corporation Presents at UBS Global Healthcare Conference 2024, Nov-14-2024 07:15 AM · Wolfe Research Initiates Repligen at Peer Perform.
Repligen Corporation | Stephens
... common stock at a price to the public of $181.00 per share. The ... Repligen Corporation (NASDAQ: RGEN) is a global life sciences company ...
Should You Investigate Repligen Corporation (NASDAQ:RGEN) At ...
Great news for investors – Repligen is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is $171.38, which ...
Is It Time To Consider Buying Repligen Corporation (NASDAQ ...
Good news, investors! Repligen is still a bargain right now. According to my valuation, the intrinsic value for the stock is $216.44, but it is ...
Why Repligen Corp's (RGEN) Stock Is Up 4.24% | AAII
Repligen Corp Stock Price: Bottom Line ... As of March 27, 2023, Repligen Corp's stock price is $167.05, which is up 4.24% from its previous ...
The Borlaug Report #8: Repligen
... companies as a % share of COGS (vs utilities and chemicals). ... In its life as a tools company, Repligen originally got most of its ...
Covington Advises Underwriters in $138 Million Stock Offering by ...
NEW YORK—Covington advised the underwriters in a $138 million follow-on public offering of common stock by Repligen Corporation. Covington ...
Top Stock Losers - Google Finance
Repligen Corp. $124.73. -$17.70. 12.43%. add_circle_outline · FCEL. FuelCell Energy ... Class A Common Stock. $320.31. -$29.92. 8.54%. add_circle_outline · AAP.
Repligen Announces Private Convertible Transaction of $600
The conversion price for the New Notes will initially be approximately $203.06 per share of Repligen's common stock, which represents a ...
Why Repligen Corp's (RGEN) Stock Is Up 11.31% | AAII
As of July 21, 2023, 4:00 PM CST, Repligen Corp's stock price was $175.34. Repligen Corp is up 11.31% from its previous closing price of $157.53 ...
Repligen prices $120M common stock, $250M debt offerings
Repligen Corp. priced concurrent public offerings of common stock and debt to raise $370 million. The Waltham, Mass.-based biotechnology company ...
Buy Repligen Stock - RGEN Stock Price Today & News - Public.com
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing ...
Form 4 REPLIGEN CORP For: May 16 Filed by - StreetInsider
Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock ...
... shares of Repligen's Common Stock as of April 1, 2020 (i) by each person who is known by the Company to beneficially own more than 5% of the ...